Skip to main content
. 2019 Jun 19;11(6):1378. doi: 10.3390/nu11061378

Table 1.

Cohort characteristics.

Variables Overall Cohort
(n = 113)
No Sarcopenia
(n = 86)
Sarcopenia
(n = 27)
p
Age (years) 80 ± 6 80 ± 6 79 ± 6 0.6
Male 77 (68%) 56 (65%) 21 (78%) 0.28
Diabetes 61 (54%) 48 (56%) 13 (48%) 0.41
Previous cardiovascular events 61 (54%) 43 (53%) 18 (67) 0.12
eGFR * (mL/min/1.73 m2) 27 ± 6 28 ± 5 25 ± 3 0.25
Creatinine 2.5 ± 1.2 2.6 ± 1.0 2.8 ± 1.3 0.29
Creatinine Clearance (mL/min/1.73 m2) 27 ± 14 28 ± 15 19 ± 12 0.01
Criteria for sarcopenia
 Reduced handgrip strength (%) 63 52 100 <0.0001
 Reduced MAMC ** (%) 34 13 100 <0.0001
 Reduced Gait Speed Test (%) 69 63 88 0.028
Physical performance
 PAS *** 7 ± 5 7 ± 5 4 ± 6 0.0014
 SPPB **** 7 ± 4 8 ± 4 6 ± 3.75 0.0008
 IADL scale ***** 5.0 ± 1.0 5.0 ± 1.0 5 ± 1.8 0.016
 Frail patients (%) ****** 50 (45%) 33 (38%) 17 (63%) 0.023
 Depression (%) 33 67 32 0.16
 Depression score 9.1 ± 6.0 8.3 ± 5.5 11.8 ± 7.1 0.008

* eGFR: estimated glomerular filtration rate; ** MAMC: mid arm muscle circumference. *** PAS: physical activity scale; **** SPPB: short physical performance battery; ***** IADL: instrumental activities of daily life (Lawton’s scale), ****** According to Frailty phenotype.